Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy

Henry C. Pitot, Richard M. Goldberg, Joel M. Reid, Jeff A. Sloan, Pam Atherton Skaff, Charles Erlichman, Joseph Rubin, Patrick A. Burch, Alex A. Adjei, Steven A. Alberts, Larry J. Schaaf, Gary Elfring, Langdon L. Miller

Research output: Contribution to journal › Article › peer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy'. Together they form a unique fingerprint.

Medicine & Life Sciences